Prostate Cancer - Results from #19380

Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy - Abstract January 31, 2015

Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study - Abstract January 31, 2015

Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model - Abstract January 31, 2015

Technology diffusion and prostate cancer quality of care - Abstract January 31, 2015

The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy - Abstract January 31, 2015

Low percentage of free prostate-specific antigen (PSA) is a strong predictor of later detection of prostate cancer among Japanese men with serum levels of total PSA of 4.0 ng/mL or less - Abstract January 31, 2015

What is the next generation therapeutic strategy for castration-resistant prostate cancer - Abstract January 30, 2015

Modelling the impact of fractionation on late urinary toxicity after postprostatectomy radiation therapy - Abstract January 30, 2015

The burden of skeletal-related events in patients with prostate cancer and bone metastasis - Abstract January 30, 2015

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: Comparison of skeletal-related events and symptomatic skeletal events - Abstract January 30, 2015

Extent of extraprostatic extension independently influences biochemical recurrence-free survival: Evidence for further pT3 subclassification - Abstract January 30, 2015

Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: Analysis of urologic and primary care practices - Abstract January 30, 2015

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: A preliminary report on disease outcomes - Abstract January 30, 2015

Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy - Abstract January 30, 2015

Primary radical therapy selection in high-risk non-metastatic prostate cancer - Abstract January 30, 2015

Rectal toxicity after intensity modulated radiotherapy for prostate cancer: Which rectal dose volume constraints should we use? - Abstract January 30, 2015

Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity Scales: A survey of radiation oncologists - Abstract January 30, 2015

Rectal toxicity after proton therapy for prostate cancer: An analysis of outcomes of prospective studies conducted at the University of Florida Proton Therapy Institute - Abstract January 30, 2015

Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer - Abstract January 29, 2015

Reclassification rates are higher among African American men than Caucasians on active surveillance - Abstract January 29, 2015

Page 970 of 1458